Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma
- PMID: 25865691
- DOI: 10.1016/s1499-3872(15)60353-8
Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma
Abstract
Background: Early recurrence of hepatocellular carcinoma (HCC) is associated with worse prognosis after liver resection. This study aimed to investigate the prognostic value of common liver enzyme markers in HCC early recurrence after curative hepatectomy and to establish a simple predictive model for HCC early recurrence.
Methods: A total of 200 patients who had undergone curative resection for HCC were retrospectively analyzed. The patients were divided into early recurrence (within 2 years) and non-early recurrence groups. Demographical characteristics, preoperative liver function parameters, surgical factors and tumor related factors of the patients were assessed by univariate analysis to identify potential significant predictors for early recurrence after resection of HCC. Parameters with statistical significance were entered into a Cox proportional hazard model to find independent risk factors. Receiver operating characteristic analysis was done to determine optimal cut-off values and the number of combined factors in multi-factor predictive model.
Results: Of 13 potential risk factors for early recurrence identified by univariate analysis, high lactate dehydrogenase (LDH>206 U/L, HR=1.711, P=0.006), high aspartate aminotransferase (AST)/alanine aminotransferase (ALT) ratio (AST/ALT>0.96, HR=1.769, P=0.006), elevated alpha-fetoprotein (AFP<8.6 ng/mL, HR=2.079, P=0.007), small resection margin (≤1 cm, HR=2.354, P<0.001) and advanced TNM stage (TNM III-IV, HR=2.164, P<0.001) were independent risk factors for early recurrence of HCC shown by multivariate analysis. Patients with three or more concurrent independent risk factors had significantly higher risk for early recurrence than those with low risk factors. The sensitivity and specificity of this predictive model are 53.6% and 80.7%, respectively (area under curve=0.741, 95% CI 0.674-0.800, P<0.0001).
Conclusions: Preoperative common liver enzyme markers, LDH and AST/ALT ratio, were independently associated with early recurrence of HCC. The combination of serum liver enzyme markers with AFP, resection margin and TNM stage better predicted early recurrence of HCC after curative resection in a simple multi-factor model.
Similar articles
-
Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.Hepatobiliary Pancreat Dis Int. 2016 Jun;15(3):266-74. doi: 10.1016/s1499-3872(16)60094-2. Hepatobiliary Pancreat Dis Int. 2016. PMID: 27298102
-
[A new prognostic score system of hepatocellular carcinoma following hepatectomy].Zhonghua Zhong Liu Za Zhi. 2017 Dec 23;39(12):903-909. doi: 10.3760/cma.j.issn.0253-3766.2017.12.005. Zhonghua Zhong Liu Za Zhi. 2017. PMID: 29262506 Chinese.
-
Elevated preoperative aspartate aminotransferase to lymphocyte ratio index as an independent prognostic factor for patients with hepatocellular carcinoma after hepatic resection.Oncotarget. 2015 Aug 7;6(22):19217-27. doi: 10.18632/oncotarget.4265. Oncotarget. 2015. PMID: 26057470 Free PMC article.
-
Alpha-fetoprotein for Diagnosis, Prognosis, and Transplant Selection.Semin Liver Dis. 2019 May;39(2):163-177. doi: 10.1055/s-0039-1677768. Epub 2019 Mar 8. Semin Liver Dis. 2019. PMID: 30849784 Review.
-
Elevated serum alpha-fetoprotein levels are associated with poor prognosis of hepatocellular carcinoma after surgical resection: A systematic review and meta-analysis.Arab J Gastroenterol. 2021 Mar;22(1):12-22. doi: 10.1016/j.ajg.2020.09.004. Epub 2021 Feb 5. Arab J Gastroenterol. 2021. PMID: 33551350
Cited by
-
Inflammation Score System using Preoperative Inflammatory Markers to Predict Prognosis for Hepatocellular Carcinoma after Hepatectomy: A Cohort Study.J Cancer. 2020 Jun 16;11(17):4947-4956. doi: 10.7150/jca.45274. eCollection 2020. J Cancer. 2020. PMID: 32742442 Free PMC article.
-
Metabolic reprogramming in the tumor microenvironment of liver cancer.J Hematol Oncol. 2024 Jan 31;17(1):6. doi: 10.1186/s13045-024-01527-8. J Hematol Oncol. 2024. PMID: 38297372 Free PMC article. Review.
-
Multi-feature weight factor extraction and survival risk assessment of hepatocellular carcinoma based on a clinical missing dataset-independent support vector machine.ILIVER. 2022 Aug 24;1(3):154-158. doi: 10.1016/j.iliver.2022.07.003. eCollection 2022 Sep. ILIVER. 2022. PMID: 40636794 Free PMC article.
-
Prognostic Impact of Aspartate Aminotransferase-to-Platelet Ratio Index and Prognostic Nutrition Index in Hepatocellular Carcinoma Patients Undergoing Resection.J Clin Med. 2025 Aug 11;14(16):5665. doi: 10.3390/jcm14165665. J Clin Med. 2025. PMID: 40869491 Free PMC article.
-
Nomogram Based on Platelet-Albumin-Bilirubin for Predicting Tumor Recurrence After Surgery in Alpha-Fetoprotein-Negative Hepatocellular Carcinoma Patients.J Hepatocell Carcinoma. 2023 Jan 13;10:43-55. doi: 10.2147/JHC.S396433. eCollection 2023. J Hepatocell Carcinoma. 2023. PMID: 36660412 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical